Alpha-Lipoic Acid (ALA), graded Moderate-evidence on Magellan — importantly, the 4-year NATHAN 1 trial found that symptoms improved but nerve-function decline was not slowed, so disease modification remains unproven. The 4-year NATHAN 1 trial found no slowing of neuropathy progression, and European regulators flag a rare insulin autoimmune syndrome (autoimmune hypoglycemia) risk.
Source: Nutrients 2023, PMID 37630823 ↗ · Nutraceuticals & Cellular Energizers · How Magellan grades evidence · Study write-up · evidence confidence: high
Alpha-lipoic acid (ALA), also called thioctic acid, is a naturally occurring sulfur-containing compound synthesized in mitochondria, where it serves as an essential cofactor for enzymes that convert nutrients into cellular energy. Being both water- and fat-soluble, ALA and its reduced form dihydrolipoic acid act as broad-spectrum, so-called universal antioxidants that scavenge free radicals, chelate metals, and regenerate other antioxidants such as vitamins C and E. It is present in small amounts in foods such as red meat, spinach and broccoli, and is manufactured for use as an oral or intravenous supplement.
The best-supported clinical use of ALA is for symptomatic diabetic peripheral neuropathy: randomized trials and meta-analyses, including the SYDNEY 2 and ALADIN programs, indicate that intravenous and oral ALA can reduce neuropathic pain, burning and numbness, with 600 mg/day identified as the optimal dose, although some longer trials such as ALADIN III found no benefit distinguishable from placebo. Importantly, the 4-year NATHAN 1 trial found that symptoms improved but nerve-function decline was not slowed, so disease modification remains unproven. Meta-analyses also report modest improvements in fasting glucose, insulin resistance, HbA1c, body weight, and inflammatory markers such as CRP and IL-6, though largely from small, heterogeneous trials. European regulators have flagged a rare association between ALA and insulin autoimmune syndrome (autoimmune hypoglycemia), especially in genetically susceptible people. This research describes the alpha-lipoic acid compound and its antioxidant mechanism itself, not this specific commercial product.
Peer-reviewed studies on the active compound — citations link to PubMed.
“ALA treatment had favorable effects by reducing sensory symptoms”
“ALA-treated patients had significantly better results regarding almost all outcome parameters”
“antioxidant supplementation with alpha-lipoic acid, vitamin C, and vitamin E reduced oxidative stress and normalized blood pressure control”
“A systematic review and meta-analysis of RCTs found alpha-lipoic acid reduced stabbing pain, burning, paraesthesia and numbness versus placebo in diabetic polyneuropathy by both oral and intravenous routes.”
“This meta-analysis found alpha-lipoic acid (600 mg/day) over 3 weeks safely and significantly improved neuropathic symptoms and deficits to a clinically meaningful degree in symptomatic diabetic polyneuropathy.”
“ALA compared with placebo may have little or no effect on impairment measured by the Neuropathy Impairment Score-Lower Limbs (NIS-LL; lower score is better) after six months (MD -1.02 points, 95% CI -2.93 to 0.89; 1 study, 245 participants; low-certainty evidence).”
Research describes the active mechanism and is not a claim about this specific product.
Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum…
Across meta-analyses and randomized trials, creatine monohydrate combined with…
In humans, randomized trials and meta-analyses most consistently show that astaxanthin…
Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after…
Yes — its active compound is linked to 23 peer-reviewed studies, summarized and cited above.
You can buy it on Amazon via the link above; Magellan earns a small affiliate commission at no extra cost to you, which does not affect the evidence grade.
Dietary supplements and devices are generally well tolerated but are not a substitute for medical care. Talk to your physician before starting, especially if you take medication or have a health condition.